Pin Oak Investment Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11K | Hold |
2,000
| – | – | 0.01% | 376 |
|
|
2026
Q1 | $9K | Hold |
2,000
| – | – | 0.01% | 377 |
|
|
2025
Q4 | $10K | Hold |
2,000
| – | – | 0.01% | 383 |
|
|
2025
Q3 | $14.5K | Hold |
2,000
| – | – | 0.01% | 336 |
|
|
2025
Q2 | $17K | Hold |
2,000
| – | – | 0.01% | 291 |
|
|
2025
Q1 | $18K | Hold |
2,000
| – | – | 0.01% | 275 |
|
|
2024
Q4 | $55K | Hold |
2,000
| – | – | 0.05% | 175 |
|
|
2024
Q3 | $54K | Hold |
2,000
| – | – | 0.05% | 179 |
|
|
2024
Q2 | $49K | Hold |
2,000
| – | – | 0.05% | 173 |
|
|
2024
Q1 | $43K | Hold |
2,000
| – | – | 0.04% | 177 |
|
|
2023
Q4 | $38K | Hold |
2,000
| – | – | 0.04% | 192 |
|
|
2023
Q3 | $32K | Hold |
2,000
| – | – | 0.04% | 201 |
|
|
2023
Q2 | $46K | Hold |
2,000
| – | – | 0.05% | 166 |
|
|
2023
Q1 | $46K | Hold |
2,000
| – | – | 0.06% | 158 |
|
|
2022
Q4 | $29K | Hold |
2,000
| – | – | 0.04% | 185 |
|
|
2022
Q3 | $38K | Hold |
2,000
| – | – | 0.05% | 152 |
|
|
2022
Q2 | $36K | Hold |
2,000
| – | – | 0.04% | 166 |
|
|
2022
Q1 | $50K | Hold |
2,000
| – | – | 0.05% | 154 |
|
|
2021
Q4 | $55K | Hold |
2,000
| – | – | 0.06% | 158 |
|
|
2021
Q3 | $65K | Hold |
2,000
| – | – | 0.07% | 147 |
|
|
2021
Q2 | $61K | Hold |
2,000
| – | – | 0.06% | 151 |
|
|
2021
Q1 | $61K | Hold |
2,000
| – | – | 0.05% | 164 |
|
|
2020
Q4 | $40K | Hold |
2,000
| – | – | 0.03% | 202 |
|
|
2020
Q3 | $26K | Hold |
2,000
| – | – | 0.03% | 213 |
|
|
2020
Q2 | $23K | Hold |
2,000
| – | – | 0.02% | 215 |
|
|
2020
Q1 | $29K | Hold |
2,000
| – | – | 0.03% | 199 |
|
|
2019
Q4 | $54K | Hold |
2,000
| – | – | 0.04% | 174 |
|
|
2019
Q3 | $57K | Hold |
2,000
| – | – | 0.05% | 179 |
|
|
2019
Q2 | $56K | Hold |
2,000
| – | – | 0.04% | 188 |
|
|
2019
Q1 | $66K | Hold |
2,000
| – | – | 0.05% | 171 |
|
|
2018
Q4 | $58K | Hold |
2,000
| – | – | 0.05% | 172 |
|
|
2018
Q3 | $92K | Hold |
2,000
| – | – | 0.07% | 157 |
|
|
2018
Q2 | $75K | Hold |
2,000
| – | – | 0.06% | 169 |
|
|
2018
Q1 | $59K | Hold |
2,000
| – | – | 0.05% | 180 |
|
|
2017
Q4 | $69K | Buy |
+2,000
| New | +$67.5K | 0.05% | 169 |
|
Other funds holding MYGN
VPC
Pin Oak Investment Advisors's MYGN Position: Q2 2026 in Review
Pin Oak Investment Advisors held its Myriad Genetics (MYGN) position steady in Q2 2026 at 2,000 shares worth $11K. The position accounts for 0.01% of the portfolio, ranked #376.
Pin Oak Investment Advisors first reported a position in MYGN in Q4 2017 and has held it in 35 quarters since. The position peaked at $92K in Q3 2018. 196 funds tracked by Wall St. Rank hold MYGN as of Q2 2026.
- Pin Oak Investment Advisors held 2,000 shares of Myriad Genetics worth $11K as of Q2 2026.
- Pin Oak Investment Advisors left its Myriad Genetics share count unchanged in Q2 2026.
- Myriad Genetics made up 0.01% of Pin Oak Investment Advisors's portfolio in Q2 2026, its #376 holding.
- Pin Oak Investment Advisors first reported a position in Myriad Genetics in Q4 2017 and has held it in 35 quarters since.
- Pin Oak Investment Advisors's Myriad Genetics position peaked at $92K in Q3 2018.
- 196 funds tracked by Wall St. Rank held Myriad Genetics as of Q2 2026.
Based on Pin Oak Investment Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.